Started from the bottom…
Dr. Phil is now Enemy #1 in the cannabis world because he has views on cannabis as outdated as Don Cherry’s views on immigration and patriotism.
The CDC in the use is (mostly) blaming vitamin E acetate on the vape crisis.
To shareholder value…
Shareholders in the US are suing Sundial over financial disclosures.
We caught up with Zenabis CEO Andrew Grieve to talk about their recent share offering.
MediPharm is having a great few weeks – capped off by this announcement last week that they will be cross-listed on NASDAQ.
To cannabis retail…
How much cannabis would Ontario sell if Ontario could sell cannabis (like Alberta)? A lot…
BUT, we learned last week that Ontario is heading in the right direction. Including farm-gate sales and click-and-collect.
And what about the “legacy” market? CBC took a look at why cannabis consumers are finding it hard to leave their old ways behind (including some insight from Business of Cannabis.)
To medical research…
Cannabis can help treat depression and suicidal thoughts among those suffering from PTSD – this from a UBC study.
To the “what’s next” file…
A ballot measure in California is circulating to legalize psilocybin mushrooms.
Now we’re here…
Does it get more Canadian than the intersection of Canada, hockey and cannabis? Ask Steve Yzerman… who allegedly grilled a potential draft pick about how cannabis use.
And it turns out there is something more Canadian than that intersection… it’s this: Canopy, cannabis and Drake. They’ll be teaming up on a new cannabis company/brand.
Finally, all things Business of Cannabis…
Our new BofC Live podcast launched last week. Episode 1 features an interview with the Honourable Anne McLellan.
.png)
The creative crew from Auxly dropped by the On A High podcast. Be the first listen:
Start-up Planter gets the Pitch Forward treatment this week. Take a listen and stay tuned for the next episode on Wednesday.
You don’t currently get this newsletter delivered to your inbox? You should. Sign up today.
